article thumbnail

ICER Finds Insurers Struggled to Provide Fair Access to Obesity Drugs

Drug Topics

The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to determine access to drugs that the organization had reviewed for cost effectiveness in 2022.

Insurance 247
article thumbnail

RAND: Hospitals charged insurers 254% more than Medicare rates in 2022

Fierce Healthcare

The gap between insurance plans and Medicare's payments to hospitals for inpatient and outpatient services widened over the course of just a couple of years, a new study from RAND Corporation | A new report from RAND Corporation highlighted just how much more employers and private insurers are paying hospitals for inpatient and outpatient services. (..)

Insurance 133
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Moody's: Outlook stable for insurers in 2022, but COVID-19's effects could linger

Fierce Healthcare

Moody's: Outlook stable for insurers in 2022, but COVID-19's effects could linger. Wed, 12/15/2021 - 13:27.

Insurance 121
article thumbnail

STAT+: FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system

STAT

The latest report accuses the PBMs – CVS Caremark, OptumRx and Express Scripts, all of which are owned by large health insurers – of boosting prices of specialty generic drugs that are sold through their own pharmacies. Specifically, the companies were able to generate more than $7.3

Insurance 141
article thumbnail

Study: Insurers spend nearly $130M a year on ivermectin prescriptions

Fierce Healthcare

Study: Insurers spend nearly $130M a year on ivermectin prescriptions. Tue, 01/18/2022 - 16:23.

Insurance 145
article thumbnail

STAT+: UnitedHealth was top insurer collecting billions in questionable Medicare payments, federal watchdog finds

STAT

A federal watchdog found that Medicare Advantage insurers collected billions of dollars in dubious payments from Medicare in a single year by using home visits and medical chart reviews to diagnose patients with conditions for which they received no follow-up care.   

Insurance 145
article thumbnail

STAT+: Medicare Advantage insurers ramped up use of technology to deny claims, Senate investigation shows

STAT

The nation’s three largest Medicare Advantage insurers increasingly refused to pay for rehabilitative care for seniors in the years after adopting sophisticated technologies to aid in their coverage decisions, a Senate investigation found. The report, conducted by the U.S.

Insurance 145